Abstract 3718: A Phase II Study of Sorafenib plus Cetuximab in colorectal cancer (CRC) expressing epidermal growth factor receptor (EGFR) and mutated K-ras
Year: 2010
Type: conference-abstract
Source: Cancer Research
Authors: Shivaani Kummar, Alice Chen, Austin Duffy, Ismail B. Turkbey, Seth Steinberg, Liang Cao, Martin E. Gutierrez, Erin Larkins, Beata Holkova, Sonja Crandon, Lamin Juwara, Yvonne Horneffer, Peter Choyke, Giovanni Melillo, Anthony J. Murgo, John Wright, James H. Doroshow
Institution: National Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2060592302
